NCT00004881View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2000

Study Completion Date

May 31, 2004

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

MVA-MUC1-IL2 vaccine

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00004881 - Vaccine Therapy in Treating Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter